AN4035

N/A

Report date: 2025/12/19 10:21:14

Base Information

Drug NameAN4035
Drug Alias NameAN4035
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CEACAM5GTPase Ras inhibitors
TargetsCarcinoembryonic antigen related cell adhesion molecule 5GTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Adlai Nortye Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Adlai Nortye Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A